We chatted to IronRidge Resources' CEO Vincent Mascolo who explains why the company has become a lithium explorer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,202.60
Bid: 1,202.40
Ask: 1,202.80
Change: -13.40 (-1.10%)
Spread: 0.40 (0.03%)
Open: 1,202.20
High: 1,236.80
Low: 1,201.20
Yest. Close: 1,216.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

GlaxoSmithKline Notes Approval Of HIV Drug Dovato In US

LONDON (Alliance News) - GlaxoSmithKline PLC on Monday said Dovato has been approved in the US as a treatment for HIV-1 infection in adults who have not previously been treated with antiretroviral

9 Apr 19 06:58

Friday broker round-up

(Sharecast News) - Purplebricks: Berenberg downgrades to sell with a target price of 80p.

5 Apr 19 12:53

GlaxoSmithKline's Juluca Suppresses HIV For Three Years In Studies

LONDON (Alliance News) - Drug major GlaxoSmithKline PLC on Wednesday noted that HIV treatment Juluca had been shown to maintain its suppression of the virus in patients after three is a two-drug a

3 Apr 19 11:59

DIRECTOR DEALINGS: Glaxo Senior Vice President Hirons Sells Shares

LONDON (Alliance News) - GlaxoSmithKline PLC on Monday said that Senior Vice President for global ethics and compliance Nick Hirons sold around GBP350,000 in shares.Hirons sold 22,178 on at

25 Mar 19 17:14

GlaxoSmithKline's Blood Cancer Drug Dreamm-1 Study Results Positive

LONDON (Alliance News) - GlaxoSmithKline PLC said Thursday it received "further positive" data from its Dreamm-1 study of patients with relapsed multiple myeloma.Multiple myeloma

21 Mar 19 17:26

TOP NEWS: GSK Gets Positive Result From Early Dostarlimab Cancer Study

LONDON (Alliance News) - GlaxoSmithKline PLC on Tuesday said data from the early-stage Garnet clinical study had promising results for the use of Dostarlimab in patients with endometrial was by by

19 Mar 19 18:24

Crossword Hires Advisory Board Chaired By Former Glaxo Security Head

LONDON (Alliance News) - Crossword Cybersecurity PLC on Tuesday said it has appointed a new advisory board that will be chaired by the former chief information security officer of GlaxoSmithKline

19 Mar 19 13:15

WINNERS & LOSERS SUMMARY: GVC Down 18% As Chiefs Sell 3 Million Shares

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - up 1.7%. The Mexican gold miner was tracking

8 Mar 19 10:50

TOP NEWS: GlaxoSmithKline Notes Positive Results From Two HIV Studies

LONDON (Alliance News) - GlaxoSmithKline PLC on Thursday said the Atlas and Flair studies showed that along-acting, injectable two-drug regimen in HIV-1 patients had similar efficacy to a daily a

8 Mar 19 07:47

LONDON MARKET PRE-OPEN: RPC Chooses Berry Offer Over Apollo

LONDON (Alliance News) - Stock prices in London are set for a lower open after disappointing Chinese economic data, while in early corporate news RPC has agreed a new takeover deal. China's in

8 Mar 19 07:39

GSK monthly HIV treatment meets targets

(Sharecast News) - Two late-stage clinical trials by GlaxoSmithKline's ViiV Healthcare joint venture of its novel, investigational, long-acting HIV treatment have both met their primary aims.

8 Mar 19 07:17

Tobacco stocks rise after FDA boss Gottlieb quits

(Sharecast News) - Shares in tobacco companies rose on Wednesday after America's chief drug and tobacco regulator unexpectedly resigned overnight.

6 Mar 19 09:20

ViiV Healthcare to collaborate with Dutch university medical center

(Sharecast News) - GlaxoSmithKline owned ViiV Healthcare announced on Tuesday a new five-year collaboration with Radboud university medical center in The Netherlands to identify new drug targets for HIV.

26 Feb 19 12:37

Pharma firms to testify in Congress over drug pricing

(Sharecast News) - Top executives of pharmaceutical companies are set to testify in front of the Senate Finance Committee on Tuesday as part of an investigation into drug pricing in the US.

26 Feb 19 08:31

GSK 'likely' to face HIV sales slowdown, UBS downgrades

(Sharecast News) - UBS thinks GSK shares will struggle to perform in the near-term if there is nervousness around its ViiV HIV business.

22 Feb 19 16:19

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.